E-LIB Suche - Ergebnisse für: Verschuuren, Jan J.

1

Change of voltage‐gated sodium channel repertoire in skelet..:

Butenko, Olena ; Jensen, Stine Marie ; Fillié‐Grijpma, Yvonne E....
European Journal of Neuroscience. 59 (2024) 12 - p. 3292-3308 , 2024

Link: https://doi.org/10.1111/..

2

Long-term safety, tolerability, and efficacy of efgartigimo..:

Howard Jr., James F. ; Bril, Vera ; Vu, Tuan...
Frontiers in Neurology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Efgartigimod demonstrates consistent improvements in patien..:

Siddiqi, Zaeem ; Rozsa, Csilla ; Saccá, Francesco...
Journal of the Neurological Sciences. 455 (2023) - p. 121094 , 2023

Link: https://doi.org/10.1016/..

4

Autoantibody subclass predominance is not driven by aberran..:

Paardekooper, Laurent M. ; Fillié-Grijpma, Yvonne E. ; van der Sluijs-Gelling, Alita J....
Clinical Immunology. 257 (2023) - p. 109817 , 2023

Link: https://doi.org/10.1016/..

5

Long-term safety, tolerability, and efficacy of efgartigimo..:

Bril, Vera ; Pasnoor, Mamatha ; Karam, Chafic...
Journal of the Neurological Sciences. 455 (2023) - p. 121089 , 2023

Link: https://doi.org/10.1016/..

6

Development and characterization of agonistic antibodies ta..:

Lim, Jamie L. ; Augustinus, Roy ; Plomp, Jaap J....
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

7

Pharmacological treatment of Lambert-Eaton Myasthenic Syndr..:

Bakker, Wisse Roelof ; Remijn-Nelissen, Linda ; Schimmel, Kirsten...
RRNMF Neuromuscular Journal. 4 (2023) 3 - p. , 2023

Link: https://doi.org/10.17161..

8

Long-Term Safety, Tolerability, And Efficacy of Efgartigimo..:

Pasnoor, Mamatha ; Bril, Vera ; Karam, Chafic...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

9

Reply to the Letter to the Editor in response to "Role of a..:

Meisel, Andreas ; Baggi, Fulvio ; Behin, Anthony...
European Journal of Neurology. 30 (2023) 4 - p. 1162-1164 , 2023

Link: https://doi.org/10.1111/..

10

Outcomes after robotic thymectomy in nonthymomatous versus ..:

Marcuse, Florit ; Hoeijmakers, Janneke G.J. ; Hochstenbag, Monique...
Neuromuscular Disorders. 33 (2023) 5 - p. 417-424 , 2023

Link: https://doi.org/10.1016/..

11

Symptomatic, pharmacological treatment of myasthenia gravis:

Remijn-Nelissen, Linda ; Bakker, Wisse ; Van Gelder, Teun..
RRNMF Neuromuscular Journal. 4 (2023) 3 - p. , 2023

Link: https://doi.org/10.17161..

12

Longitudinal Assessment of Creatine Kinase, Creatine/Creati..:

van de Velde, Nienke M. ; Koeks, Zaïda ; Signorelli, Mirko...
Neurology. 100 (2023) 9 - p. , 2023

Link: https://doi.org/10.1212/..

13

In memoriam: Prof. Dr. John H. J. Wokke (1952–2022):

Notermans, Nicolette ; Verschuuren, Jan ; de Visser, Marianne
Journal of Neurology. 269 (2022) 10 - p. 5197-5197 , 2022

Link: https://doi.org/10.1007/..

14

Role of autoantibody levels as biomarkers in the management..:

Meisel, Andreas ; Baggi, Fulvio ; Behin, Anthony...
European Journal of Neurology. 30 (2022) 1 - p. 266-282 , 2022

Link: https://doi.org/10.1111/..

15

Long-term Safety, Tolerability, and Efficacy of Efgartigimo..:

Howard, James ; Bril, Vera ; Vu, Tuan...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..